Stock Movers

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Shares of Gilead Sciences (GILD) slipped in premarket trading after the company agreed to buy biotech firm Arcellx Inc. (ACLX) in a deal with an equity value of up to $7.8 billion as the US drugmaker seeks to boost its cancer drug pipeline. Gilead, which owns 11.5% of Arcellx’s outstanding stock, will pay $115 per share in cash, with a contingent payment of $5 per share dependent on future sales, according to a statement Monday. The price is almost double Arcellx’s closing price on Friday.
- Shares of Merck & Co. (MRK) rallied ahead of the US market open after the Wall Street Journal reported the company plans to split its main pharmaceutical unit in two as it prepares for the approaching patent expiry of its best-selling drug. The US drugmaker will separate its human-health division into a business that will house its cancer medications — including blockbuster immunotherapy Keytruda — and another for its non-cancer therapies, such as the HPV vaccine Gardasil, the newspaper reported.
- Shares of Domino's Pizza (DPZ) jumped premarket after the company reported a larger-than-expected rise in comparable sales, as consumers were drawn to the pizza chain’s budget-friendly pies. The Ann Arbor, Michigan-based company made more money by selling more food to its stores, charging higher prices for ingredients and collecting more fees from franchise operators for advertising and royalties, it said in a Monday statement.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:
- Novo Nordisk says Cagrisema fell short of Lilly’s Zepbound in trial, sending shares into freefall.
- Johnson Matthey shares fall as much as 17%, most since 2021, after Honeywell cut the price it’s paying for the UK company’s Catalyst Technologies business.
- ABN Amro Bank shares rose as much as 3.7%, the most since November, after BofA Global Research raises its recommendation on the lender to buy from neutral, noting attractive valuation and improved profitability that could lead to more buybacks.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Johnson Matthey shares fall as much as 17%, most since 2021, after Honeywell cut the price it’s paying for the UK company’s Catalyst Technologies business.
- Enel plans to deepen its commitments in the US and Europe over the next three years, with a fresh wave of investments in renewable energy projects such as wind power and battery storage.
- SAP's among the european software and cybersecurity stocks falling, tracking price moves among US peers on Friday, after Anthropic introduced a new security feature for its Claude AI model.
See omnystudio.com/listener for privacy information.

Big Tech earnings are still in focus with Home Depot, HP, and Dell all reporting in the coming days.
Bloomberg's Nathan Hager previews the numbers with Kristine Aquino, Bloomberg Managing Editor for Markets Live.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Genuine Parts (GPC) slipped after it announced it would split itself in two, separating its automotive parts and repairs business and its industrial distributing arm into separate companies. The company is best known for its Napa Auto Parts retail operations. Genuine Parts in September struck a deal with activist investor Elliott to add new directors to the board.
- Omnicom (OMC) shares surged over the week, rising as much as 12% in trading on Thursday for its biggest intraday advance since February 2022. Traders were enthusiastic about the advertising agency after it reported fourth-quarter revenue that beat estimates. The company’s board also authorized a $5 billion share buyback.
- Blue Owl (OWL) shares continue to tumble after it restricted withdrawals from one of its retail focused private credit funds, a fresh blow to a sector that’s faced heightened scrutiny in recent weeks. Blue Owl’s decision highlights a key risk for retail investors drawn to private credit: such funds offer less liquidity than public markets, and firms can block their investors from cashing in.
See omnystudio.com/listener for privacy information.